NCT05277714 Neurofeedback Based on Near-infrared Spectroscopy as a Therapy for Food Addiction in Obese Subjects.
| NCT ID | NCT05277714 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rennes University Hospital |
| Condition | Obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2022-05-25 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2022-05-25 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The hypothesis is that the increase in dlPFC brain activity via near-infrared spectroscopy-based Neurofeedback (fNIRS-based NF) training based on near-infrared spectroscopy would allow an improvement of the eating behavior, thus promoting a long-term weight loss in obese subjects. Patients will be trained during a month with 8 NF sessions and results based on clinical data and different questionnaires results will be compared between inclusion and 3 months later
Eligibility Criteria
Inclusion Criteria: * Eligible for obesity surgery according to the 2009 French High Authority on Health (HAS) criteria (BMI ≥40 or BMI ≥35 with comorbidities) * Right-handed * Presenting a food addiction determined by the YFAS 2.0 questionnaire ; * Affiliated to a social security system; * Having given free and informed consent in writing. Exclusion Criteria: * Psychotic psychiatric disorders (schizophrenic disorders and bipolar disorders); * Psychotropic drugs, except antidepressants stabilized for at least 3 weeks and benzodiazepines * Addiction to alcohol or other psychoactive substances (except tobacco); * History of bariatric surgery; * Current treatment in the nutrition unit; * Insufficient command of French; * Pregnant or breast-feeding woman; * Persons of legal age under legal protection (safeguard of justice, curatorship, guardianship), persons deprived of liberty. * Contraindications to fMRI * Inability to perform the fNIRS procedure due to blockage or attenuation of the light at the capillary level
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05277714 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 55 Years, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05277714 currently recruiting?
Yes, NCT05277714 is actively recruiting participants. Contact the research team at marie-laure.gervais@chu-rennes.fr for enrollment information.
Where is the NCT05277714 trial being conducted?
This trial is being conducted at Rennes, France.
Who is sponsoring the NCT05277714 clinical trial?
NCT05277714 is sponsored by Rennes University Hospital. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.